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Ethical dilemmas arise in managing head and neck cancers during pregnancy. The timing of treatment is
an important determinant on foetal wellbeing. Diagnostic and treatment modalities may harm the foetus,
while delaying or choosing suboptimal treatment in order to preserve foetal health may worsen maternal
outcome. A multidisciplinary approach should be adopted to enable parents and clinicians to make the
best clinical decision. We report on two cases. Case 1 is a 34-year-old female who presented with squamous
cell carcinoma of the tongue at 29 weeks’ gestation. Partial glossectomy, selective neck dissection and poste-
rior tibial flap reconstruction was performed at 31 weeks. She underwent induction and early delivery 
at 38 weeks prior to receiving radiotherapy. Case 2 is a 36-year-old female who presented with carcinoma
of the cervical oesophagus complicated by tracheal invasion, thyroid and cervical lymph node metastasis
at 13 weeks’ gestation. Pregnancy was terminated at 16 weeks. She received a course of neoadjuvant
chemoirradiation. [Asian J Surg 2008;31(4):199–203]
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Introduction
Cancer is the second leading cause of death in women of
childbearing age.1 One in 118 women diagnosed with can-
cer is pregnant at the time of diagnosis.2 Oral cancer ac-
counts for less than 2% of all cancers during pregnancy.3
The most common pregnancy-associated head and neck
cancers include larynx, thyroid, melanoma and lymphoma.4
The challenge in managing head and neck cancers dur-
ing pregnancy is the potential counterbalance between
maternal and foetal health. Diagnostic and treatment
modalities may harm the foetus, while delaying treatment
or choosing suboptimal treatment in order to preserve
foetal wellbeing may worsen maternal outcome.
The aim of this article is to describe the principles of
managing non-thyroid head and neck cancers during
pregnancy. Two short case studies will be presented to
highlight the fine balance between the optimal treatment
of cancer versus the preservation of a healthy foetus.
Case reports
Case 1
A 34-year-old female, at 29 weeks of gestation (gravida 1,
para 0), presented with a 6-month history of a non-healing
ulcer over the right tongue edge. Antenatal history was
uneventful. On physical examination, she was found to
have a 1.5×2.5 cm ulcerative growth over the right tongue
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edge. Biopsy confirmed squamous cell carcinoma. Panendo-
scopy showed no evidence of synchronous tumour and
there was no cervical lymph node metastasis on ultra-
sonography of the neck region. Clinical staging of the
tumour was T2N0M0.
Preoperatively, she was assessed by obstetricians and
was given steroid prophylaxis 24 hours before the opera-
tion for foetal maturation (two doses of intramuscular
betamethasone 12 mg Q12H) and 20 mg subcutaneous
enoxaparin immediately before the operation. The pre-
operative foetal heart rate was 140 beats per minute
before incision. No intraoperative foetal monitoring was
required. At 31 weeks of gestation, transoral excision of
the right lateral posterior portion of the tongue together
with the floor of the mouth was performed with at least
1.5 cm margin around the ulcer and a deep margin of
1 cm (Figure 1). Selective neck dissection with the removal
of levels I to III cervical lymph nodes was performed.
Meanwhile, a free posterior tibial fasciocutaneous flap
was harvested by a second team of surgeons during
tumour resection in order to shorten operative time. The
flap measured 7 × 11 cm. It consisted of two perforators
at 8 cm and 13.5 cm proximal to the medial malleolus,
and an intact posterior tibial artery, vein and saphenous
nerve. The flap was used to reconstruct the intraoral
defect, inset with 3’O vicryl (Figure 2) after vascular anas-
tomosis under operative microscope using 9’O nylon
(right superior thyroid artery to posterior tibial artery; a
branch of internal jugular vein to posterior tibial vein). A
long saphenous vein was harvested as interpositional
graft with cut ends of the posterior tibial artery. The
donor site was closed with 3’O vicryl, 4’O prolene and a
split thickness skin graft from the left thigh. The neck
wound was closed with 3’O vicryl and 4’O nylon. The
duration of general anaesthesia was 8 hours 42 minutes
and blood loss was 250 mL. Pathological examination of
the specimen confirmed squamous cell carcinoma with
clear resection margins. In view of her young age and the
general aggressive nature of tongue carcinoma, adjuvant
radiotherapy was offered.
She underwent induction of labour and forceps-assisted
delivery at 38 weeks’ gestation. Both mother and baby
were well post delivery (female, birth weight 2,445 g).
Subsequently, she received 60 Gy of external radiation to
the tumour bed and right upper cervical region. She was
followed-up regularly at the outpatient clinic. There was no
tumour recurrence and satisfactory speech and swallowing
function returned after a period of rehabilitation.
Case 2
A 36-year-old female presented with a 2-month history 
of a progressively enlarging neck mass at 13 weeks’ ges-
tation. There was no shortness of breath, dysphagia or
weight loss. On physical examination, she was noted to
have a hard thyroid mass and a 1-cm left level IV cervical
lymph node. Barium swallow showed a malignant oesoph-
ageal stricture at level C6–7. Panendoscopy showed an
obstructive tumour growth at the cervical oesophagus
Figure 1. Right tongue edge ulcerative tumour. Excision line 
is marked in ink: right lateral posterior portion of the tongue
including the floor of the mouth with at least 1.5 cm margin
around the ulcer.
Figure 2. Reconstruction of the intraoral defect with a free poste-
rior tibial fasciocutaneous flap.
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with evidence of invasion of the posterior tracheal wall.
Biopsy confirmed squamous cell carcinoma. Endoscopic
ultrasound revealed a full thickness tumour infiltration
as well as multiple paratracheal lymph node metastasis.
Fine needle aspiration was performed for the left cervical
lymphadenopathy and cytology yielded metastatic carci-
noma. Magnetic resonance imaging (MRI) and positron
emission tomography–computed tomography (PET-CT)
scans confirmed locally advanced carcinoma of the cervi-
cal oesophagus with extensive invasion of the trachea,
thyroid cartilage and the thyroid gland as well as the pres-
ence of cervical lymph node metastasis (Figures 3 and 4).
Surgical resection required total laryngectomy, manubrium
resection, circumferential pharyngectomy, and radical
neck dissection followed by gastric pull-up. This would
result in loss of voice and impairment of swallowing func-
tions, whilst the chance of curative resection was minimal.
Therefore, after discussion with the patient, neoadjuvant
chemoirradiation was offered instead of surgery. Pregnancy
was terminated at 16 weeks of gestation. She went on 
to receive three doses of systemic chemotherapy (tax-
otere 100 mg, cisplatin 100 mg, 5-fluorouracil 1,000 mg).
Reassessment of PET-CT showed a good response with a
marked reduction in glycolytic activity over the cervical
oesophageal tumour mass; hypermetabolic cervical nodal
metastases were no longer seen. There was no evidence of
distant metastasis. She is currently well and is scheduled
for concurrent chemoirradiation with weekly carboplatin
infusion (200 mg over 30 minutes) using intensity modu-
lated radiotherapy to give 2 Gy/fr at 97% intensity level,
5 fr/week to 66 Gy.
Discussion
Cancer is generally a disease that occurs more commonly
in men at a later stage in life.5 In recent years, an increase
in the incidence of younger females with head and neck
cancers has been noted.6–8 The incidence of head and neck
cancers during pregnancy is also rising as women nowa-
days tend to delay pregnancy until their late reproductive
years.9
The occurrence of cancer during pregnancy is of con-
siderable interest in view of the resulting dilemmas in
management, including the priority of maternal versus
foetal health and the acceptable level of foetal risk for
maternal treatment. Treatment of head and neck cancers
occurring during pregnancy depends on the prognosis of
the specific malignancy (type, site and stage), the course
of the pregnancy, and the wishes of the patient and her
spouse.5 One must first decide whether there will be
immediate termination of the pregnancy so as to elimi-
nate this complicating factor in the treatment of disease,
as in Case 2. If pregnancy is to be continued, one must con-
sider the various options and timing of diagnostic and
Figure 3. Magnetic resonance imaging sagittal section of the
head and neck shows carcinoma of the cervical oesophagus with
invasion into the trachea, thyroid cartilage and thyroid gland.
Figure 4. Magnetic resonance imaging transverse section of the
head and neck shows tracheal invasion and the presence of 
cervical lymph node metastasis.
■ CHOW et al ■
202 ASIAN JOURNAL OF SURGERY VOL 31 • NO 4 • OCTOBER 2008
treatment modality, taking into account the altered phys-
iological parameters during pregnancy, the effect of general
anaesthesia, and the risks of radiation and chemotherapy
to both mother and foetus.
The surgical management of all patients with head
and neck tumours involves long and technically demanding
surgeries. Altered physiological parameters during preg-
nancy aggravate potential complications. For instance,
the hypercoagulable state of pregnancy increases the risk
of thromboembolic disease and anastomotic thrombosis.
This is of particular concern when there is microvascular
tissue transfer. As in Case 1, low molecular weight heparin
(enoxaparin) may be used prophylactically since it does
not cross the placenta.10 The mass effect of the gravid
uterus causes gastric displacement, which predisposes to
aspiration and diaphragmatic compression, which in turn
decreases functional residual capacity. Compression on
the aorta and inferior vena cava together with the physio-
logical increase in blood volume, heart rate and cardiac
output means that close haemodynamic monitoring is
crucial intraoperatively.
Obstructive head and neck tumours themselves may
pose difficulties in intubation. General anaesthesia has an
adverse effect on the foetus and the effect varies with ges-
tational age: teratogenicity in the first trimester; sponta-
neous abortion in trimesters one and two; preterm labour
in trimester three. The second trimester is the preferred
time for surgery to take place since the physiological
effects of pregnancy are less florid and the side effects of
general anaesthesia minimal.5,11,12 Some have advocated
dividing head and neck tumour surgery into two stages to
reduce anaesthetic time and minimize the risk of hypoxia.5
However, there is no proven benefit. In fact, more harm
may result from subjecting mother and foetus to repeated
general anaesthesia with an additional risk of disease pro-
gression. In order to save time and minimize anaesthetic
risks, a two-team approach may be adopted such that
tumour resection and reconstruction surgery can take
place simultaneously, as in Case 1.
Radiation exposure may result in structural malfor-
mation, organ dysfunction, growth retardation, teratoge-
nesis and foetal death. It may also predispose the foetus
to childhood cancers, germ cell mutations and sterility
later in life.12 Side effects of radiotherapy cause signifi-
cant maternal morbidity, such as tissue stiffness, oral
ulceration and osteoradionecrosis, impairing quality of
life and caregiving abilities. Furthermore, there is an
increased risk of developing another primary tumour in
later life.13 Compared with CT scanning, MRI is the safer
and preferred diagnostic modality in head and neck can-
cers during pregnancy since it does not employ ionizing
radiation.14,15 Abdominal and pelvic shields may be used
to minimize foetal radiation exposure.16–18 If feasible, it 
is best to defer radiotherapy until after delivery, as in 
Case 1.
The effects of chemotherapy vary with gestational age.
Teratogenicity and spontaneous abortion may occur
when chemotherapy is given in the first trimester; myelo-
toxicity, organ toxicity, intrauterine growth retardation,
preterm labour and still birth may occur when given in
the second and third trimesters.12,13 In view of such poten-
tially devastating effects, it is rarely administered during
pregnancy. Indeed, some recommend termination of preg-
nancy for patients who have received chemotherapy during
the first trimester.19,20
Conclusion
The timing of treatment is an important determinant of
foetal wellbeing. A multidisciplinary approach should be
adopted to enable parents as well as clinicians to strive to
achieve the optimal balance between cancer treatment
and preservation of foetal health.
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